Abstract:Introduction Most clinical studies have demonstrated that low-intensity extracorporeal shockwave therapy (Li-ESWT) can improved erectile function in patients with erectile dysfunction (ED). The EAU guideline recommended to use Li-ESWT for mild vasculogenic ED patients. However, the therapeutic advantages of Li-ESWT combined with phosphodiesterase type 5 inhibitors (PDE5i) have not been explored clearly in clinical practice for mild and moderate ED patients. Objective To compare the therapeutic effects of Li-ESWT and Li-ESWT combined with PDE5i in mild and moderate ED patients with 8≤IIEF-5≤16 from a multicenter clinical study in China. Methods Patients with ED which IIEF-5 score is less than 22 and aged 18–60 years old were enrolled from three clinical centers from Jun. 2019 to Mar. 2023. The demographic data, International Index of Erectile Function-5 (IIEF-5), erectile hardness score (EHS) and self-reported symptom questions were collected. Patients were treated by a linear low-energy shock waves generator (Renova). Low-intensity shock wave (energy density of 0.09mJ/mm2) treatments were applied (once a week, 4 weeks in total, 5000 shocks each time). Patients in Li-ESWT combined with PDE5i group took 5mg of tadalafil once a day for one continuous month during ESWT. Comparative analyses of pre- and post-treatment and intergroup were used for statistics. Results In total, 42 ED cases (37.43±11.86 years) in Li-ESWT group and 116 cases (37.41±10.14 years) in combined group were enrolled for analysis. The IIEF-5 score and EHS in both groups were significantly improved after 1 month treatment (p<0.01). Compared with Li-ESWT group, patients in combined group significantly had higher self-reported efficiency (61.2% vs. 47.6%, p=0.013), IIEF-5 scores (15.34±7.15 vs. 13.96±7.71, p=0.039) and EHS (2.85±0.82 vs. 2.69±0.89, p=0.050). In the mild and moderate ED (with 8≤IIEF-5≤16) sub-group, 30 ED cases (36.81±10.99 years) in Li-ESWT group and 96 cases (36.80±10.69 years) in combined group were enrolled for analysis. The combined regimen showed better therapeutic advantages, including effective parameters IIEF-5(14.50±6.74 vs. 12.87±8.54, p=0.040), EHS (2.85±0.75 vs. 2.81±0.67, p=0.046) and self-reported efficiency (64.2% vs. 54.1%, p=0.001). Conclusions Li-ESWT can effectively improve erectile function in this multicenter clinical study in China, and the combination of Li-ESWT with daily use PDE5i had a better therapeutic effect on Chinese ED patients, especially on mild and moderate ED. Long-term follow-up with large sample study need to be developed for exploring the optimal therapeutic regimen. Disclosure No.

[Pde-5I Combined with RigiScan-based Audiovisual Sexual Stimulation Test Versus Nocturnal Penile Tumescence Test in Evaluation of Erectile Function].

[Real-Time Rigiscan Monitoring and Color Doppler Ultrasonography in the Diagnosis of Erectile Dysfunction].

AB029. The clinical significance of RigiScan plus detection

Dynamic Observation of Penile Hemodynamic Change in Patients with Vasculogenic Erectile Dysfunction after Prostaglandin E1 Treatment

[RigiScan monitoring assists tadalafil medication in the treatment of penile ED]

The value of audiovisual sexual stimulation with virtual reality in diagnosing erectile dysfunction

AB044. Initial Analysis of PDE5i and Visual-Auditory Sexual Stimulation Rigiscan Plus Detection Results of 1,896 Cases in Outpatients

Nocturnal Penile Tumescence and the Effect of Tadalafil on Erectile Dysfunction

Role of RigiScan parameters in differentiation of vascular erectile dysfunction

A Study of Differences in Penile Dorsal Nerve Somatosensory Evoked Potential Testing among Healthy Controls and Patients with Primary and Secondary Premature Ejaculation.

AB085. Systematic Review and Meta-Analysis of Phosphodiesterase Type 5 Inhibitors for the Treatment of Female Sexual Dysfunction

The value of shear wave elastography combined with red blood cell distribution width in evaluating arterial erectile dysfunction

Study on the hemodynamic parameters of the erection penis evoked by Sildenaifl combined with audio-visual sexual stimulation

Correlation between nocturnal penile tumescence and vascular endothelial function

(281) Low-Intensity Shockwave Therapy Combined with Tadalafil 5mg Daily has Better Efficacy for Mild and Moderate Erectile Dysfunction: The Preliminary Results of a Multicenter Clinical Study in China

A Study of the Relationship Between Objective Tests to Diagnose Erectile Dysfunction and Markers of Cardiovascular Disease

A novel strategy to induce penile erection during penile doppler ultrasound: oral sildenafil administration plus alprostadil injection

Association between testosterone levels and RigiScan parameters of patients with erectile dysfunction

Why a combined intracavernosal injection with trimix and oral sildenafil is reliable therapy in the ultrasonographic evaluation of erectile dysfunction

Vacuum Erection Device Plus Once-Daily Tadalafil Improve Clinical Outcomes after Extracorporeal Shock Wave Therapy in Men Affected by Erectile Dysfunction Associated with Peyronie's Disease

Clinical Application of the Nocturnal Penile Tumescence Test of Electrobioimpedance Volumetric Assessment